StockCIK 1127537
Pulmonx Corp (LUNG): Insider Trades and Fund Holdings
In the past 12 months, Pulmonx Corp insiders reported 0 open-market purchases worth $0 and 4 sales worth $177K; 0 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$177KSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 3, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 3 | Glendon E. French IIICEO | ▼ SELL | $95K |
| Sep 3 | David Aaron LehmanGeneral Counsel | ▼ SELL | $32K |
| Sep 3 | Srikanth RadhakrishnanChief Science & Techn. Officer | ▼ SELL | $32K |
| Sep 3 | Geoffrey Beran RoseChief Commercial Officer | ▼ SELL | $18K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Glendon E. French III | CEO | 0 | $0 | 1 | $95K |
| David Aaron Lehman | General Counsel | 0 | $0 | 1 | $32K |
| Srikanth Radhakrishnan | Chief Science & Techn. Officer | 0 | $0 | 1 | $32K |
| Geoffrey Beran Rose | Chief Commercial Officer | 0 | $0 | 1 | $18K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report LUNG
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 425,110 | $553K | ▲ +32.7% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →